Prior to these findings, IRF5 was identified as a critical mediator of MyD88-dependent TLR signaling, leading to the expression/production of multiple pro-inflammatory cytokines including type I IFNs, IL6, TNFα, IL12, IL23, and others implicated in autoimmune disease pathogenesis (62, 72–76). This evidence concerns the gene IRF5 and autoimmune disease.